Renal failure (acute).
Kellum
John
J
Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Leblanc
Martine
M
Venkataraman
Ramesh
R
D000111:Acetylcysteine / Q000627:therapeutic use; D058186:Acute Kidney Injury / Q000517:prevention & control / Q000628:therapy*; D000617:Aminoglycosides / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D000666:Amphotericin B / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D018818:Fenoldopam / Q000627:therapeutic use; D005440:Fluid Therapy; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D045265:Natriuretic Peptides / Q000627:therapeutic use; D006435:Renal Dialysis; D017582:Renal Replacement Therapy; D013806:Theophylline / Q000627:therapeutic use
D000617:Aminoglycosides; D002121:Calcium Channel Blockers; D004234:Diuretics, Osmotic; D045265:Natriuretic Peptides; D000628:Aminophylline; D008353:Mannitol; D000666:Amphotericin B; D013806:Theophylline; D018818:Fenoldopam; D004298:Dopamine; D000111:Acetylcysteine